Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Continuous glucose monitors are small devices that automatically track your blood sugar, aka your blood glucose level, ...

Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

The implementation of an inpatient continuous glucose monitoring policy was accurate and feasible among patients and nurses. Implementation of continuous glucose monitoring (CGM) in the hospital ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

Senseonics, a medtech manufacturer developing long-term, implantable continuous glucose monitoring (CGM) systems, and ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

The Continuous Glucose Monitoring Market is Growing at a CAGR of 7.80%, Driven by the Increasing Prevalence of Prediabetes ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...